Coronary artery calcification, an improvement in risk classification: Need for reappraisal?

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1415-1417
Number of pages3
JournalJournal of the American College of Cardiology
Issue number17
StatePublished - Oct 19 2010

Bibliographical note

Funding Information:
Dr. Duprez has received honoraria as consultant for Novartis and Pfizer; honoraria as member of speaker's bureau for Pfizer, Novartis, Merck, and Forest; and research grants from Roche and Novartis .


  • Framingham risk estimate
  • coronary calcium score
  • coronary heart disease
  • intermediate risk

Cite this